News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nymox Pharmaceutical (NYMX) Signs New Sales And Marketing Agreement for Alzheimer's Test With Kyung Min Meditech Co. Ltd. In Korea



6/14/2006 1:29:16 PM

HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--June 14, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX - News) announced today that it has entered into an agreement with Kyung Min Meditech Co., Ltd. for the marketing and sale of the Company's AlzheimAlert(TM) kit in the Korea Republic. AlzheimAlert(TM) provides physicians with a valuable tool for the diagnosis of Alzheimer's disease by measuring levels of a biomarker for Alzheimer's disease in patient urine samples. Kyung Min Meditech is a Korean medical device distributor headquartered in Seoul, Korea.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES